Contemporary concepts of open angle glaucoma suggest that the current
emphasis on reduction of elevated intraocular pressure could be augmen
ted by other therapeutic approaches. In this article, we describe sign
ificant recent developments in the molecular and cellular biology and
neuropharmacology of nerve damage that are likely, in coming years, to
suggest new therapeutic approaches to the management of glaucoma. The
se developments may lead to the achievement of pharmacologic protectio
n of the optic nerve from damage or possibly promotion of reversal of
damage. We review selected studies of excitotoxins and N-methyl-D-aspa
rtate receptor antagonists, Ca2+-induced damage and calcium channel bl
ockers, the intracellular messenger nitric oxide and its perturbation,
free-radical damage and scavengers, nerve regeneration, and growth fa
ctors. Several basic research questions are posed, answers to which ma
y transform our concepts of glaucoma therapy.